Document Detail


Noninvasive assessment of pediatric inflammatory bowel disease with ¹⁸F-fluorodeoxyglucose-positron emission tomography and computed tomography.
MedLine Citation:
PMID:  21042220     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
OBJECTIVES: ¹⁸F-fluorodeoxyglucose (FDG)-positron emission tomography (PET) is a less invasive diagnostic tool and promising in detecting gastrointestinal lesions of pediatric inflammatory bowel disease (IBD) patients. Co-registration of low-dose computed tomography (CT) could lead to improvements in the assessment of disease. Therefore, this retrospective study evaluates the value of PET±CT in pediatric IBD patients.
PATIENTS AND METHODS: We analyzed ¹⁸F-FDG-PET scans without (n=24) or with combined (n=21) low-dose CT in children (18 females, 27 males, age: 3.7-16.7 years, median 13.2 years) who presented with the diagnosis of IBD (n=45). Results of PET±CT scans and conventional diagnostic procedures (endoscopy, histology, and ultrasound) were compared by a segment-based analysis.
RESULTS: Overall, 253 segments of the gastrointestinal tract (GIT) were explored by endoscopy/histology and ¹⁸F-FDG-PET±CT. Twenty-five additional small bowel segments were assessed by abdominal ultrasound and further 152 GIT segments not reached during endoscopy were evaluated by PET±CT. PET±CT revealed a segment-based sensitivity, specificity, positive predictive value, negative predictive value, and an accuracy for the detection of GIT lesions of 82, 97, 96, 88, and 91%, respectively. The patient-based sensitivity and specificity was 97 and 100%, respectively. Interestingly, the co-registration of CT did not improve the diagnostic informative value.
CONCLUSION: FDG-PET±CT is especially suitable for the assessment of IBD in children. The radiation exposure of 3-7 mSv is justified by the accuracy of this approach. FDG-PET seems to be a reliable tool for detecting inflamed gut segments in IBD with high sensitivity and specificity. The co-registration of CT had no additional benefit.
Authors:
Jan Däbritz; Niklas Jasper; Markus Loeffler; Matthias Weckesser; Dirk Foell
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European journal of gastroenterology & hepatology     Volume:  23     ISSN:  1473-5687     ISO Abbreviation:  Eur J Gastroenterol Hepatol     Publication Date:  2011 Jan 
Date Detail:
Created Date:  2010-12-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9000874     Medline TA:  Eur J Gastroenterol Hepatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  81-9     Citation Subset:  IM    
Affiliation:
Department of General Pediatrics, University Children's Hospital Muenster, Münster, Germany. Jan.Daebritz@ukmuenster.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  DSM-5 proposals for mood disorders: a cost-benefit analysis.
Next Document:  Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C pro...